A start-up life science company with a focus on specialty markets. Our goal is to develop innovative delivery systems that improve the clinical outcome of select approved drugs including combination drugs for existing and/or additional therapeutic indications. We plan to develop our novel products utilizing a virtual company business model, one that we have successfully executed in the past. We have previously developed, marketed and distributed pharmaceutical products in oncology, HIV disease and the endocrine markets.
Our management team and network of consultant experts are experienced at founding and growing companies from the earliest stages of development through product approval and commercialization.
Thank You! Your message has been sent.
Something went wrong, try refreshing and submitting the form again.